Franceschi et al., 2004 - Google Patents
Gene therapy approaches for bone regenerationFranceschi et al., 2004
View PDF- Document ID
- 12021279766759315371
- Author
- Franceschi R
- Yang S
- Rutherford R
- Krebsbach P
- Zhao M
- Wang D
- Publication year
- Publication venue
- Cells Tissues Organs
External Links
Snippet
Gene therapy represents a promising approach for delivering regenerative molecules to specific tissues including bone. Several laboratories have shown that virus-based BMP expression vectors can stimulate osteoblast differentiation and bone formation in vivo. Both …
- 210000000988 Bone and Bones 0 title abstract description 60
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Franceschi et al. | Gene therapy approaches for bone regeneration | |
| Franceschi | Biological approaches to bone regeneration by gene therapy | |
| Musgrave et al. | Gene therapy and tissue engineering in orthopaedic surgery | |
| Baltzer et al. | Regional gene therapy to enhance bone repair | |
| Gysin et al. | Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats | |
| Zhang et al. | The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration | |
| Edwards et al. | Sonic hedgehog gene-enhanced tissue engineering for bone regeneration | |
| Virk et al. | “Same day” ex-vivo regional gene therapy: a novel strategy to enhance bone repair | |
| Winn et al. | Gene therapy approaches for modulating bone regeneration | |
| Bleich et al. | Gene therapy approaches to regenerating bone | |
| Balmayor et al. | Gene therapy for bone engineering | |
| Feng et al. | Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells | |
| Partridge et al. | Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies | |
| Ashinoff et al. | Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis | |
| Madry et al. | Gene therapy for human osteoarthritis: principles and clinical translation | |
| Egermann et al. | The potential of gene therapy for fracture healing in osteoporosis | |
| Bougioukli et al. | Gene therapy for bone repair using human cells: Superior osteogenic potential of bone morphogenetic protein 2–transduced mesenchymal stem cells derived from adipose tissue compared to bone marrow | |
| Park et al. | Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model | |
| Carofino et al. | Gene therapy applications for fracture-healing | |
| Evans et al. | Gene therapy for the treatment of musculoskeletal diseases | |
| Hannallah et al. | Gene therapy in orthopaedic surgery | |
| Shi et al. | Growth factor transgenes interactively regulate articular chondrocytes | |
| Srouji et al. | Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects | |
| Okubo et al. | Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage | |
| Rodriguez-Merchan et al. | The role of gene therapy in cartilage repair |